IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IOBT is expected to report earnings to fall 11.50% to -35 cents per share on November 05
Q3'25
Est.
$-0.35
Q2'25
Missed
by $0.03
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.17
Q3'24
Missed
by $0.07
The last earnings report on August 14 showed earnings per share of -40 cents, missing the estimate of -37 cents. With 20.33M shares outstanding, the current market capitalization sits at 84.33M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IOBT showed earnings on August 14, 2025. You can read more about the earnings report here.